ZEROFOS-DS is a 1st in India double strength calcium acetate phosphate binder which comes in a strength of two conventional calcium acetate tablet to reduce the increased pill burden in CKD patients and improve their adherence to therapy. It belongs to a class of medications called phosphate binders. People with advanced kidney failure retain phosphate leading to too much phosphate in their bodies (hyperphosphatemia). High phosphate levels cause hyperparathyroidism, which leads to abnormal bone formation and calcium deposits in tissues. ZEROFOS-DS works by holding onto phosphate from the diet so that it can pass out of your body. Dialysis removes some phosphate from blood, but it is difficult to remove enough to keep phosphate levels balanced. ZEROFOS-DS is used to prevent high blood phosphate levels in patients who are on dialysis due to severe kidney disease.
Calcium Acetate 1334mg
MODE OF ACTION:
Calcium acetate and other calcium salts are phosphate binders. They work by binding with the phosphate in the food you eat, so that it is eliminated from the body without being absorbed. Binding phosphate in the intestines reduces absorption of phosphate into the body.
- First time in world DCGI approved double strength calcium acetate
- Reduce pill burden for better patient compliance
- Improved treatment outcomes
- Better patient adherence
- Least medication error
- Effective and safe phosphate binder
- Hyperphosphatemia in End Stage Renal Failure (On Dialysis)
1 tablets with each meal
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.